BetterScholar BetterScholar

E. Burdick

Journal of the American Medical Association, New England Journal of Medicine, Critical Care Medicine, Journal of the American Society of Nephrology, Pediatrics, J. Am. Medical Informatics Assoc. Show more
14
Role
Title
Level Year L/R
🐬 Acute kidney injury, mortality, length of stay, and costs in hospitalized patients.
G. Chertow, E. Burdick, Melissa M. Honour, J. Bonventre, D. Bates 		11 2005
11
🐬
🐜 Effect of computerized physician order entry and a team intervention on prevention of serious medication errors.
12 auth. D. Bates, L. Leape, D. Cullen, N. Laird, L. Petersen, J. Teich, ... E. Burdick, M. Hickey, S. Kleefield, B. Shea, M. Vander Vliet, D. Seger 		11 1998
11
🐜
🐜 The Costs of Adverse Drug Events in Hospitalized Patients
9 auth. D. Bates, N. Spell, D. Cullen, E. Burdick, N. Laird, L. Petersen, ... S. Small, B. Sweitzer, L. Leape 		10 1997
10
🐜
🐜 Effect of reducing interns' work hours on serious medical errors in intensive care units.
11 auth. C. Landrigan, J. Rothschild, John W. Cronin, R. Kaushal, E. Burdick, J. Katz, ... C. Lilly, Peter H. Stone, S. Lockley, D. Bates, C. Czeisler 		10 2004
10
🐜
🐜 Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
7 auth. L. Leape, D. Cullen, M. Clapp, E. Burdick, H. Demonaco, J. Erickson, ... D. Bates 		10 1999
10
🐜
🐜 Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-analysis of the Published Literature
7 auth. G. Colditz, T. Brewer, C. Berkey, Mary E. Wilson, E. Burdick, H. Fineberg, ... F. Mosteller 		10 1994
10
🐜
🐜 Adverse drug events in ambulatory care.
11 auth. T. Gandhi, S. Weingart, J. Borus, A. Seger, J. Peterson, E. Burdick, ... D. Seger, Kirstin Shu, F. Federico, L. Leape, D. Bates 		10 2003
10
🐜
🐜 Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature.
11 auth. G. Colditz, Timothy, F. Brewer, S. Catherine, Berkey, Mary, ... E. Wilson, E. Burdick, Harvey, Fineberg, F. Mosteller 		9 1994
9
🐜
🐜 The Critical Care Safety Study: The incidence and nature of adverse events and serious medical errors in intensive care*
11 auth. J. Rothschild, C. Landrigan, John W. Cronin, R. Kaushal, S. Lockley, E. Burdick, ... Peter H. Stone, C. Lilly, J. Katz, C. Czeisler, D. Bates 		9 2005
9
🐜
🐜 The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.
7 auth. G. Colditz, C. Berkey, F. Mosteller, T. Brewer, Mary E. Wilson, E. Burdick, ... H. Fineberg 		9 1995
9
🐜
🐬 Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units.
D. Cullen, B. Sweitzer, D. Bates, E. Burdick, A. Edmondson, L. Leape 		9 1997
9
🐬
🐜 The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group
9 auth. D. Bates, N. Spell, D. Cullen, E. Burdick, N. Laird, L. Petersen, ... S. Small, B. Sweitzer, L. Leape 		9 1997
9
🐜
🐜 Research Paper: Identifying Adverse Drug Events: Development of a Computer-based Monitor and Comparison with Chart Review and Stimulated Voluntary Report
10 auth. A. Jha, G. Kuperman, J. Teich, L. Leape, Brian Shea, E. Rittenberg, ... E. Burdick, D. Seger, M. V. Vliet, D. Bates 		9 1998
9
🐜
🐜 The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group.
9 auth. D. Bates, N. Spell, D. Cullen, E. Burdick, N. Laird, L. Petersen, ... S. Small, B. Sweitzer, L. Leape 		9 1998
9
🐜